08/19/2025
6:09 AM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2025
11:19 AM | FMR LLC (Filed by)
Viking Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
07/23/2025
4:01 PM | Viking Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/03/2025
2:30 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2025
2:31 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2025
2:31 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2025
12:01 PM | Lian Brian (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2025
12:05 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2025
12:07 PM | Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/27/2025
4:20 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2025
9:43 AM | FMR LLC (Filed by)
Viking Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for VKTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Viking Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/24/2025
3:37 PM | Viking Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/23/2025
4:25 PM | Viking Therapeutics (Filer)
| Form DEFR14A | |
04/23/2025
4:26 PM | Viking Therapeutics (Filer)
| Form DEFA14A | |
04/23/2025
3:01 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2025
9:00 AM | BlackRock, Inc. (Filed by)
Viking Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
04/14/2025
6:26 PM | FOEHR MATTHEW W (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2025
6:05 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
| Form 4/A | |
04/08/2025
4:23 PM | Viking Therapeutics (Filer)
| Form DEFA14A | |
04/08/2025
4:25 PM | Viking Therapeutics (Filer)
| Form ARS | |
04/02/2025
5:29 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
6:05 AM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2025
3:32 PM | Viking Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/06/2025
7:15 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
7:16 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
7:11 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
7:12 PM | FOEHR MATTHEW W (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
7:13 PM | Rowland Charles A Jr (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
7:13 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
7:14 PM | MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
7:14 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:32 PM | Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/06/2025
4:25 PM | Mancini Marianna (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/06/2025
4:16 PM | Lian Brian (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
5:22 PM | MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
5:13 PM | MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/04/2024
12:54 PM | VANGUARD GROUP INC (Filed by)
Viking Therapeutics (Subject)
| Form SC 13G/A | |
11/04/2024
5:31 AM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
8:48 PM | Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
3:37 PM | Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024
6:27 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
$100 Trillion “AI Metal” Found in American Ghost Town (Ad) Jeff Brown recently traveled to a ghost town in the middle of an American desert…
To investigate what could be the biggest technology story of this decade.
In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom…
And only one company here in the U.S. can mine this obscure metal. Click here to get the details on this virtual monopoly. |
10/25/2024
6:28 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
3:10 PM | Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
4:00 PM | Viking Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/23/2024
3:09 PM | Viking Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2024
11:26 AM | STATE STREET CORP (Filed by)
Viking Therapeutics (Subject)
| Form SC 13G/A | |
09/20/2024
8:20 PM | Lian Brian (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
8:21 PM | SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
3:29 PM | Lian Brian (Reporting)
Viking Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
MarketBeat All Access